These effects, together with a past report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the strategy of targeting ACKR3 as a unique strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-connected Conditions. At that time, Microsoft Promotion https://josephv849pfv5.wikitron.com/user